Crimean-Congo hemorrhagic fever

Archives of Iranian Medicine

Volumn 10, Issue 2, 2007, Pages 204-214

  Mardani, Masoud ^a   Keshtkar Jahromi, Maryam ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crimean Congo hemorrhagic fever; Tick borne virus; Treatment

Indexed keywords

AZAURIDINE; NAIRO VIRUS VACCINE; RIBAVIRIN; SELENAZOFURIN; TIAZOFURIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANEMIA; ANTIVIRAL ACTIVITY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE CARRIER; DISEASE COURSE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG TOLERABILITY; DRUG URINE LEVEL; ENDEMIC DISEASE; EVIDENCE BASED MEDICINE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INCUBATION TIME; INFECTION RISK; LABORATORY TEST; NAIRO VIRUS; NONHUMAN; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; PROGNOSIS; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEROPREVALENCE; TICK; TREATMENT DURATION; VIRUS DETECTION; VIRUS HEMORRHAGIC FEVER; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROGNOSIS; RIBAVIRIN; RISK FACTORS;

EID: 34247600550     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Lacy MA, Smego RA Jr. Viral hemorrhagic fevers. In: Aranoff SA, ed. Advances in Pediatric Infectious Diseases. St. Louis: Mosby Year Book; 1997: 21-53.
2. Wallace MR, Hale BR, Utz GC, Olson PE, Earhart KC, Thornton SA, et al. Endemic infectious diseases of Afghanistan. Clin Infect Dis. 2002; 34(suppl 5): S17l-S207.
3. Gonzalez JP, LeGuenno B, Guillaud M, Wilson ML. A fatal case of Crimean-Congo hemorrhagic fever in Mauritania: virological and serological evidence suggesting epidemic transmission. Trans R Soc Trop Med Hyg. 1990; 84: 573-576.
4. Morrill JC, Soliman AK, Imam IZ, Botros BA, Moussa MI, Watts DM. Serological evidence of Crimean-Congo hemorrhagic fever viral infection among camels imported into Egypt. J Trop Med Hyg. 1990; 93: 201-204.
5. Darvishi M, Ataee B, Chinikar S, Jalali N, Mardani M, Mirkhani M. Seroepidemiology of Crimean-Congo hemorrhagic fever in local and imported sheep in Isfahan Province of Iran. Clin Microbiol Infect. 2005; 11 (suppl 2): 649.
6. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979; 15: 307-317.
7. Athar MN, Baqai HZ, Ahmad M, Khalid MA, Bashir N, Ahmad AM, et al. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan. Am J Trop Med Hyg. 2003; 69: 284-287.
8. Khan AS, Maupin GO, Rollin PE, Noor AM, Shurie HH, Shalabi AG, et al. An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg. 1997; 57: 519-525.
9. Rodriguez LL, Maupin GO, Ksiazek TG, Rollin PE, Khan AS, Schwarz TF, et al. Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg. 1997; 57: 512-518.
10. Karti S, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004; 19: 1379-1384.
11. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004; 64: 145-160.
12. Swanepoel R. Nairovirus infections. In: Porterfield JS, ed. Exotic Vital Infections. London: Chapman and Hall; 1995: 285-293.
13. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis. 2003; 36: 1613-1618.
14. Mardani M, Bijani B. Clinico-epidemiologic features and outcome analysis of hemorrhagic forms of Crimean-Congo hemorrhagic fever (CCHF) in Iran. 41st Annual Meeting of IDSA, October 9 - 12, 2003; San-Diego, United States: 763.
15. Sheikh AS, Sheikh AA, Sheikh NS, Rafi US, Asif M, Afridi F, et al. Bi-annual surge of Crimean-Congo hemorrhagic fever (CCHF): a five-year experience. Int J Infect Dis. 2005; 9: 37-42.
16. Gubler DJ, Reiter P, Ebi KL, Yap W, Nasci R, Patz JA. Climate variability and change in the United States: potential impacts on vector- and rodent-borne diseases. Environ Health Perspect. 2001; 109: 223-233.
17. Estrada-Pena A. Forecasting habitat suitability for ticks and prevention of tick-borne diseases. Vet Parasitol. 2001; 98: 111-132.
18. Burt FJ, Swanepoel R. Molecular epidemiology of African and Asian Crimean-Congo hemorrhagic fever isolates. Epidemiol Infect. 2005; 133: 659-666.
19. Masayuki S, Qing T, Bawudong S, Lei H, Yuzhen Z. Possible horizontal transmission of Crimean-Congo hemorrhagic fever virus from a mother to her child. Jpn J Infec Dis. 2004; 57: 55-57.
20. Fisher-Hoch SP, Khan AJ, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean-Congo hemorrhagic fever treated with oral ribavirin. Lancet. 1995; 346: 472-475.
21. Mardani M. Nosocomial Crimean-Congo hemorrhagic fever in Iran, 1999 - 2000. Clin Microbiol Infec. 2001; 7(suppl 1): 213.
22. van Eeden PJ, van Eeden SF, Joubert JR, King JB, van de Wal BW, Michell WL, et al. A nosocomial outbreak of Crimean-Congo hemorrhagic fever at Tygerberg Hospital. Part I. Clinical features. S Afr Med J. 1985; 68: 711-715.
23. Casals J. Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. Proc Soc Exp Biol Med. 1969; 131: 233-236.
24. Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP, Miller GB. A common-source outbreak of Crimean-Congo hemorrhagic fever on a dairy farm. S Afr Med J. 1985; 68: 635-637.
25. van de Wal BW, Joubert JR, van Eeden PJ, King JB. A nosocomial outbreak of Crimean-Congo hemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures. S Afr Med J. 1985; 68: 729-732.
26. Shepherd AJ, Swanepoel R, Shepherd SP, Leman PA, Blackburn NK, Hallet AF. A nosocomial outbreak of Crimean-Congo hemorrhagic fever at Tygerberg Hospital. Part V. Virological and serological observations. S Afr Med J. 1985; 68: 733-736.
27. Weber DJ, Rutala WA. Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin Infect Dis. 2001; 32: 446-456.
28. Centers for Disease Control (CDC). Management of patients with suspected viral hemorrhagic fever. MMWR Morb Mortal Wkly Rep. 1988; 37(suppl 3): 1-16.
29. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management, JAMA. 2002; 287: 2391-2405.
30. Izadi S, Holakouie-Naieni K, Madjdzadeh SR, Nadim A. Crimean-Congo hemorrhagic fever in Sistan and Balouchestan Province of Iran, a case-control study on epidemiological characteristics. Inter J Infect Dis. 2004; 8: 299-306.
31. El-Azazy OM, Scrimgeour EM. Crimean-Congo hemorrhagic fever virus infection in the western province of Saudi Arabia. Trans R Soc Trop Med Hyg. 1997; 91: 275-278.
32. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, et al. Crimean-Congo hemorrhagic fever in eastern Turkey: clinical features, risk factors, and efficacy of ribavirin therapy. J Infect. 2006; 52: 207-215.
33. Ergonul O. Crimean-Congo hemorrhagic fever. Lancet Infect Dis. 2006; 6: 203-214.
34. Mardani M, Rahnavardi M, Rajaeinejad M, Holakoui-Naini K, Pourmalek F, Rostami M, et al. Crimean Congo hemorrhagic fever among health care workers in Iran. A seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007. In press.
35. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989; 11(suppl 4): 794-800.
36. Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP, McGillivray GM, Erasmus MJ, et al. Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg. 1987; 36: 120-132.
37. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo hemorrhagic fever outbreak in Middle Anatolia: a multicenter study of clinical features and outcome measures. J Med Microbiol. 2005; 54: 385-389.
38. Celikbas A, Ergonul O, Dokuzoguz B, Eren S, Baykam N, Polat-Duzgun A. Crimean-Congo hemorrhagic fever infection simulating acute appendicitis. J Infect. 2005; 50: 363-365.
39. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. The characteristics of Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clin Infect Dis. 2004; 39: 285-289.
40. Schwarz TF, Nsanze H, Ameen AM. Clinical features of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Infection. 1997; 25: 364-367.
41. Swanapoel R, Coetzer JA. Rift Valley fever. In: Royal Society (Great Britain), ed. Infectious Diseases of Livestock with Special Reference to Southern Africa. Vol 1. New York: Oxford University Press; 1994.
42. Peters CJ, Kuehne RW, Mercado RR, Le Bow RH, Spertzel RO, Webb PA. Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am J Epidemiol. 1974; 99: 425-433.
43. Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med. 2004; 10: 110-121.
44. Feldman H, Jones S, Klenk HD, Schnittler HJ. Ebola virus: from discovery to vaccine. Nat Immunol. 2003; 3: 677-685.
45. Schnittler HJ, Feldman H. Viral haemorrhagic fever - a vascular disease? Thromb Haemost. 2003; 89: 967-972.
46. Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med. 1997; 121: 839-846.
47. Swanepoel R, Leman PA, Burt FJ, Jardine J, Verwoerd DJ, Capua I, et al. Experimental infection of ostriches with Crimean-Congo hemorrhagic fever virus. Epidemiol Infect. 1998; 121: 427-432.
48. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of IL-6, IL-10, and TNF-alpha in patients with Crimean-Congo hemorrhagic fever, J Infect Dis. 2006; 193: 941-944.
49. Crimean-Congo hemorrhagic fever. WHO fact sheets 2001 November: 208.
50. Shepherd AJ, Swanepoel R, Leman PA, Shepherd SP. Comparison of methods for isolation and titration of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol. 1986; 24: 654-656.
51. Shepherd AJ, Swanepoel R, Leman PA. Antibody response in Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989; 11 (suppl 4): 801-806.
52. Chinikar S, Mirahmadi R, Mazaheri V, Nabeth P, Saron MF. A survey of Crimean-Congo hemorrhagic fever in Iran. Clin Microbiol Infect. 2003; 9 (suppl 1): 81.
53. Wray SK, Gilbert BE, Knight V. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res. 1985; 5: 39-48.
54. Wray SK, Gilbert BE, Noall MW, Knight V. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res. 1985; 5: 29-37.
55. Paroni R, Del Puppo M, Borghi C, Sirtori CR, Galli-Kienle M. Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers. Int J Clin Pharmacol Ther. 1989; 27: 302-307.
56. Connor JD. Ribavirin pharmacokinetics. Pediatr Infect Dis J. 1990; 9(suppl): S91-S92.
57. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med. 1986; 314: 20-26.
58. Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991; 164: 1119-1127.
59. Paragas J, Whitehouse CA, Bray M, Endy TP. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res. 2004; 62: 21-25.
60. Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, Haller O, et al. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol. 2004; 78: 4323-4329.
61. Centers for Disease Control (CDC). Management of patients with suspected Viral Hemorrhagic Fever - United States. MMWR. 1995; 44: 475-479.
62. Frame JD. Clinical features of Lassa fever in Liberia. Rev Infect Dis. 1989; 11(suppl 4): 783-789.
63. Sheikh AS, Sheikh AA, Sheikh NS, Tariq M. Ribavirin: an effective treatment of Crimean-Congo hemorrhagic fever. Pak J Med Sci. 2004; 20: 201-206.
64. Centers for Disease Control and Prevention. Viral hemorrhagic fever: initial management of suspected and confirmed cases. MMWR Morb Mortal Wkly Rep. 1983; 32(suppl 2): 27-38.
65. Shuman M. Abnormalities of platelet and vascular function. In: Goldman L, Bennett JC, eds. Cecil Textbook of Medicine. 21st ed. Philadelphia: WB Saunders Company; 2000: 996-1012.
66. van Eeden PJ, van Eeden SF, Joubert JR, King JB, van de Wal BW, Groenwald JH. A nosocomial outbreak of Crimean-Congo hemorrhagic fever at Tygerberg Hospital. Part II. Management of patients. S Afr Med J. 1985; 68: 718-721.
67. Mardani M. Crimean-Congo hemorrhagic fever. In: Mortazavi-Tabatabaei SA, ed. Important Zoonoses in Iran. Tehran: Ministry of Health and Education; 2005: 219-220.